Share Price and Basic Stock Data
Last Updated: April 3, 2025, 1:24 am
PEG Ratio | 0.00 |
---|
Competitors of Gujarat Alkalies & Chemicals Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Caprolactam Chemicals Ltd | 18.9 Cr. | 41.2 | 65.0/38.2 | 11.6 | 0.00 % | 6.86 % | 3.67 % | 10.0 | |
Standard Industries Ltd | 124 Cr. | 19.8 | 39.0/17.5 | 134 | 20.1 | 5.31 % | 6.83 % | 6.28 % | 5.00 |
Gujarat Alkalies & Chemicals Ltd | 4,752 Cr. | 648 | 900/484 | 842 | 0.00 % | 3.83 % | 3.88 % | 10.0 | |
GHCL Ltd | 6,133 Cr. | 639 | 779/472 | 10.2 | 331 | 1.88 % | 20.6 % | 17.3 % | 10.0 |
Tata Chemicals Ltd | 21,685 Cr. | 852 | 1,247/756 | 44.5 | 871 | 1.76 % | 7.81 % | 2.32 % | 10.0 |
Industry Average | 6,745.20 Cr | 488.17 | 61.63 | 392.45 | 1.52% | 9.52% | 6.89% | 9.17 |
Quarterly Result
Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 1,075 | 1,141 | 1,128 | 1,127 | 1,123 | 1,138 | 913 | 971 | 921 | 1,002 | 977 | 991 | 1,029 |
Expenses | 709 | 792 | 778 | 969 | 885 | 936 | 882 | 955 | 941 | 998 | 923 | 945 | 951 |
Operating Profit | 366 | 349 | 351 | 159 | 238 | 202 | 31 | 16 | -20 | 4 | 54 | 46 | 78 |
OPM % | 34% | 31% | 31% | 14% | 21% | 18% | 3% | 2% | -2% | 0% | 6% | 5% | 8% |
Other Income | 3 | 7 | 6 | 22 | 6 | 8 | 12 | 71 | 5 | 3 | 3 | 49 | 15 |
Interest | 1 | 1 | 2 | 3 | 8 | 8 | 10 | 11 | 11 | 12 | 11 | 11 | 10 |
Depreciation | 50 | 52 | 50 | 60 | 79 | 88 | 89 | 95 | 96 | 97 | 97 | 100 | 98 |
Profit before tax | 317 | 303 | 305 | 118 | 157 | 115 | -57 | -18 | -123 | -102 | -50 | -16 | -15 |
Tax % | 37% | 27% | 37% | 49% | 44% | 38% | 0% | -0% | -6% | -55% | -11% | 15% | -27% |
Net Profit | 201 | 221 | 191 | 61 | 87 | 71 | -57 | -18 | -115 | -46 | -45 | -18 | -11 |
EPS in Rs | 27.42 | 30.05 | 25.99 | 8.24 | 11.87 | 9.67 | -7.78 | -2.50 | -15.68 | -6.29 | -6.06 | -2.48 | -1.53 |
Last Updated: February 28, 2025, 7:40 pm
Below is a detailed analysis of the quarterly data for Gujarat Alkalies & Chemicals Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is ₹1,029.00 Cr.. The value appears strong and on an upward trend. It has increased from 991.00 Cr. (Sep 2024) to ₹1,029.00 Cr., marking an increase of 38.00 Cr..
- For Expenses, as of Dec 2024, the value is ₹951.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 945.00 Cr. (Sep 2024) to ₹951.00 Cr., marking an increase of 6.00 Cr..
- For Operating Profit, as of Dec 2024, the value is ₹78.00 Cr.. The value appears strong and on an upward trend. It has increased from 46.00 Cr. (Sep 2024) to ₹78.00 Cr., marking an increase of 32.00 Cr..
- For OPM %, as of Dec 2024, the value is 8.00%. The value appears strong and on an upward trend. It has increased from 5.00% (Sep 2024) to 8.00%, marking an increase of 3.00%.
- For Other Income, as of Dec 2024, the value is ₹15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 49.00 Cr. (Sep 2024) to ₹15.00 Cr., marking a decrease of 34.00 Cr..
- For Interest, as of Dec 2024, the value is ₹10.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 11.00 Cr. (Sep 2024) to ₹10.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Dec 2024, the value is ₹98.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 100.00 Cr. (Sep 2024) to ₹98.00 Cr., marking a decrease of 2.00 Cr..
- For Profit before tax, as of Dec 2024, the value is ₹-15.00 Cr.. The value appears strong and on an upward trend. It has increased from -16.00 Cr. (Sep 2024) to ₹-15.00 Cr., marking an increase of 1.00 Cr..
- For Tax %, as of Dec 2024, the value is -27.00%. The value appears to be improving (decreasing) as expected. It has decreased from 15.00% (Sep 2024) to -27.00%, marking a decrease of 42.00%.
- For Net Profit, as of Dec 2024, the value is ₹-11.00 Cr.. The value appears strong and on an upward trend. It has increased from -18.00 Cr. (Sep 2024) to ₹-11.00 Cr., marking an increase of 7.00 Cr..
- For EPS in Rs, as of Dec 2024, the value is -1.53. The value appears strong and on an upward trend. It has increased from -2.48 (Sep 2024) to -1.53, marking an increase of 0.95.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 6, 2025, 4:08 pm
Metric | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|
Sales | 1,995 | 2,070 | 2,455 | 3,161 | 2,725 | 2,429 | 3,759 | 4,516 | 3,807 | 3,999 |
Expenses | 1,660 | 1,622 | 1,669 | 2,046 | 2,148 | 2,072 | 2,774 | 3,568 | 3,775 | 3,817 |
Operating Profit | 335 | 448 | 786 | 1,115 | 577 | 357 | 984 | 949 | 32 | 182 |
OPM % | 17% | 22% | 32% | 35% | 21% | 15% | 26% | 21% | 1% | 5% |
Other Income | 45 | 56 | 106 | 62 | 90 | 67 | 46 | 42 | 90 | 70 |
Interest | 10 | 13 | 15 | 21 | 14 | 15 | 6 | 19 | 45 | 44 |
Depreciation | 107 | 111 | 127 | 140 | 162 | 174 | 198 | 276 | 377 | 392 |
Profit before tax | 262 | 381 | 749 | 1,016 | 491 | 235 | 826 | 695 | -300 | -184 |
Tax % | 16% | 19% | 29% | 32% | 32% | 29% | 32% | 41% | -21% | |
Net Profit | 220 | 307 | 534 | 690 | 332 | 166 | 560 | 410 | -237 | -120 |
EPS in Rs | 29.90 | 41.85 | 72.78 | 93.98 | 45.22 | 22.57 | 76.22 | 55.78 | -32.25 | -16.36 |
Dividend Payout % | 15% | 12% | 9% | 9% | 18% | 35% | 13% | 42% | -43% |
YoY Net Profit Growth
Year | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 39.55% | 73.94% | 29.21% | -51.88% | -50.00% | 237.35% | -26.79% | -157.80% |
Change in YoY Net Profit Growth (%) | 0.00% | 34.40% | -44.73% | -81.10% | 1.88% | 287.35% | -264.14% | -131.02% |
Gujarat Alkalies & Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2016-2017 to 2023-2024.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 4% |
3 Years: | 16% |
TTM: | 1% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 0% |
Stock Price CAGR | |
---|---|
10 Years: | 15% |
5 Years: | 21% |
3 Years: | -11% |
1 Year: | -11% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 5% |
3 Years: | 4% |
Last Year: | -4% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 14, 2024, 11:38 pm
Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 |
Reserves | 2,854 | 3,282 | 3,748 | 4,222 | 4,522 | 5,301 | 5,826 | 6,066 | 6,002 | 6,112 |
Borrowings | 295 | 353 | 291 | 247 | 205 | 498 | 594 | 597 | 544 | 603 |
Other Liabilities | 671 | 726 | 859 | 988 | 1,090 | 1,282 | 1,484 | 1,599 | 1,404 | 1,625 |
Total Liabilities | 3,894 | 4,435 | 4,970 | 5,531 | 5,891 | 7,154 | 7,977 | 8,335 | 8,023 | 8,413 |
Fixed Assets | 1,821 | 2,073 | 2,104 | 2,300 | 2,610 | 2,587 | 2,702 | 4,250 | 4,617 | 4,491 |
CWIP | 83 | 151 | 252 | 307 | 445 | 1,109 | 1,787 | 544 | 95 | 157 |
Investments | 854 | 1,016 | 1,145 | 1,065 | 1,242 | 2,092 | 2,110 | 1,831 | 2,093 | 2,377 |
Other Assets | 1,136 | 1,196 | 1,469 | 1,858 | 1,594 | 1,366 | 1,379 | 1,710 | 1,218 | 1,388 |
Total Assets | 3,894 | 4,435 | 4,970 | 5,531 | 5,891 | 7,154 | 7,977 | 8,335 | 8,023 | 8,413 |
Below is a detailed analysis of the balance sheet data for Gujarat Alkalies & Chemicals Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹73.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 73.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹6,112.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,002.00 Cr. (Mar 2024) to ₹6,112.00 Cr., marking an increase of 110.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹603.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 544.00 Cr. (Mar 2024) to ₹603.00 Cr., marking an increase of 59.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹1,625.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,404.00 Cr. (Mar 2024) to ₹1,625.00 Cr., marking an increase of 221.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹8,413.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8,023.00 Cr. (Mar 2024) to ₹8,413.00 Cr., marking an increase of 390.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹4,491.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,617.00 Cr. (Mar 2024) to ₹4,491.00 Cr., marking a decrease of 126.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹157.00 Cr.. The value appears strong and on an upward trend. It has increased from 95.00 Cr. (Mar 2024) to ₹157.00 Cr., marking an increase of 62.00 Cr..
- For Investments, as of Sep 2024, the value is ₹2,377.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,093.00 Cr. (Mar 2024) to ₹2,377.00 Cr., marking an increase of 284.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹1,388.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,218.00 Cr. (Mar 2024) to ₹1,388.00 Cr., marking an increase of 170.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹8,413.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,023.00 Cr. (Mar 2024) to ₹8,413.00 Cr., marking an increase of 390.00 Cr..
Notably, the Reserves (₹6,112.00 Cr.) exceed the Borrowings (603.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 40.00 | 95.00 | 495.00 | -246.00 | 372.00 | -141.00 | 390.00 | 352.00 | -512.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|
Debtor Days | 60 | 58 | 60 | 56 | 50 | 43 | 29 | 23 | 17 |
Inventory Days | 99 | 94 | 147 | 99 | 92 | 88 | 101 | 111 | 93 |
Days Payable | 99 | 125 | 154 | 134 | 126 | 111 | 101 | 119 | 86 |
Cash Conversion Cycle | 60 | 27 | 53 | 22 | 17 | 21 | 29 | 15 | 25 |
Working Capital Days | 90 | 83 | 99 | 96 | 107 | 20 | 8 | 16 | 18 |
ROCE % | 11% | 18% | 24% | 11% | 5% | 13% | 11% | -4% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
ICICI Prudential Regular Savings Fund | 75,047 | 0.18 | 5.96 | 75,047 | 2025-04-02 | 0% |
Motilal Oswal Nifty Microcap 250 Index Fund | 31,263 | 0.18 | 2.48 | 75,047 | 2025-04-02 | -58.34% |
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | -32.25 | 55.78 | 76.22 | 22.57 | 45.22 |
Diluted EPS (Rs.) | -32.25 | 55.78 | 76.22 | 22.57 | 45.22 |
Cash EPS (Rs.) | 33.38 | 115.99 | 103.46 | 46.46 | 67.36 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 827.30 | 835.97 | 803.30 | 731.86 | 625.79 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 827.30 | 835.97 | 803.30 | 731.86 | 625.79 |
Revenue From Operations / Share (Rs.) | 518.34 | 615.01 | 511.82 | 330.82 | 371.00 |
PBDIT / Share (Rs.) | 30.79 | 157.51 | 140.60 | 57.96 | 90.89 |
PBIT / Share (Rs.) | -20.60 | 119.92 | 113.67 | 34.21 | 68.86 |
PBT / Share (Rs.) | -26.67 | 117.27 | 112.83 | 32.11 | 66.94 |
Net Profit / Share (Rs.) | -18.01 | 78.39 | 76.52 | 22.72 | 45.32 |
NP After MI And SOA / Share (Rs.) | -32.25 | 55.78 | 76.22 | 22.57 | 45.22 |
PBDIT Margin (%) | 5.93 | 25.61 | 27.47 | 17.51 | 24.49 |
PBIT Margin (%) | -3.97 | 19.49 | 22.20 | 10.34 | 18.55 |
PBT Margin (%) | -5.14 | 19.06 | 22.04 | 9.70 | 18.04 |
Net Profit Margin (%) | -3.47 | 12.74 | 14.95 | 6.86 | 12.21 |
NP After MI And SOA Margin (%) | -6.22 | 9.06 | 14.89 | 6.82 | 12.18 |
Return on Networth / Equity (%) | -3.89 | 6.67 | 9.48 | 3.08 | 7.22 |
Return on Capital Employeed (%) | -2.07 | 11.75 | 11.52 | 3.84 | 9.42 |
Return On Assets (%) | -2.95 | 4.91 | 7.01 | 2.31 | 5.63 |
Long Term Debt / Equity (X) | 0.05 | 0.07 | 0.09 | 0.08 | 0.02 |
Total Debt / Equity (X) | 0.08 | 0.09 | 0.10 | 0.08 | 0.03 |
Asset Turnover Ratio (%) | 0.46 | 0.55 | 0.49 | 0.37 | 0.47 |
Current Ratio (X) | 1.23 | 1.68 | 1.49 | 1.78 | 2.60 |
Quick Ratio (X) | 0.67 | 1.13 | 1.01 | 1.41 | 2.15 |
Inventory Turnover Ratio (X) | 6.75 | 6.45 | 6.97 | 6.16 | 6.40 |
Dividend Payout Ratio (NP) (%) | -73.02 | 17.92 | 10.49 | 35.44 | 17.69 |
Dividend Payout Ratio (CP) (%) | 123.03 | 10.70 | 7.75 | 17.27 | 11.89 |
Earning Retention Ratio (%) | 173.02 | 82.08 | 89.51 | 64.56 | 82.31 |
Cash Earning Retention Ratio (%) | -23.03 | 89.30 | 92.25 | 82.73 | 88.11 |
Interest Coverage Ratio (X) | 5.07 | 59.43 | 168.00 | 27.53 | 47.54 |
Interest Coverage Ratio (Post Tax) (X) | -1.97 | 30.58 | 92.43 | 11.79 | 24.71 |
Enterprise Value (Cr.) | 5324.43 | 4435.11 | 6873.06 | 2607.27 | 1735.82 |
EV / Net Operating Revenue (X) | 1.40 | 0.98 | 1.83 | 1.07 | 0.63 |
EV / EBITDA (X) | 23.55 | 3.83 | 6.66 | 6.13 | 2.60 |
MarketCap / Net Operating Revenue (X) | 1.30 | 0.95 | 1.75 | 1.04 | 0.60 |
Retention Ratios (%) | 173.02 | 82.07 | 89.50 | 64.55 | 82.30 |
Price / BV (X) | 0.81 | 0.70 | 1.12 | 0.47 | 0.35 |
Price / Net Operating Revenue (X) | 1.30 | 0.95 | 1.75 | 1.04 | 0.60 |
EarningsYield | -0.04 | 0.09 | 0.08 | 0.06 | 0.20 |
After reviewing the key financial ratios for Gujarat Alkalies & Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is -32.25. This value is below the healthy minimum of 5. It has decreased from 55.78 (Mar 23) to -32.25, marking a decrease of 88.03.
- For Diluted EPS (Rs.), as of Mar 24, the value is -32.25. This value is below the healthy minimum of 5. It has decreased from 55.78 (Mar 23) to -32.25, marking a decrease of 88.03.
- For Cash EPS (Rs.), as of Mar 24, the value is 33.38. This value is within the healthy range. It has decreased from 115.99 (Mar 23) to 33.38, marking a decrease of 82.61.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 827.30. It has decreased from 835.97 (Mar 23) to 827.30, marking a decrease of 8.67.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 827.30. It has decreased from 835.97 (Mar 23) to 827.30, marking a decrease of 8.67.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 518.34. It has decreased from 615.01 (Mar 23) to 518.34, marking a decrease of 96.67.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 30.79. This value is within the healthy range. It has decreased from 157.51 (Mar 23) to 30.79, marking a decrease of 126.72.
- For PBIT / Share (Rs.), as of Mar 24, the value is -20.60. This value is below the healthy minimum of 0. It has decreased from 119.92 (Mar 23) to -20.60, marking a decrease of 140.52.
- For PBT / Share (Rs.), as of Mar 24, the value is -26.67. This value is below the healthy minimum of 0. It has decreased from 117.27 (Mar 23) to -26.67, marking a decrease of 143.94.
- For Net Profit / Share (Rs.), as of Mar 24, the value is -18.01. This value is below the healthy minimum of 2. It has decreased from 78.39 (Mar 23) to -18.01, marking a decrease of 96.40.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is -32.25. This value is below the healthy minimum of 2. It has decreased from 55.78 (Mar 23) to -32.25, marking a decrease of 88.03.
- For PBDIT Margin (%), as of Mar 24, the value is 5.93. This value is below the healthy minimum of 10. It has decreased from 25.61 (Mar 23) to 5.93, marking a decrease of 19.68.
- For PBIT Margin (%), as of Mar 24, the value is -3.97. This value is below the healthy minimum of 10. It has decreased from 19.49 (Mar 23) to -3.97, marking a decrease of 23.46.
- For PBT Margin (%), as of Mar 24, the value is -5.14. This value is below the healthy minimum of 10. It has decreased from 19.06 (Mar 23) to -5.14, marking a decrease of 24.20.
- For Net Profit Margin (%), as of Mar 24, the value is -3.47. This value is below the healthy minimum of 5. It has decreased from 12.74 (Mar 23) to -3.47, marking a decrease of 16.21.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is -6.22. This value is below the healthy minimum of 8. It has decreased from 9.06 (Mar 23) to -6.22, marking a decrease of 15.28.
- For Return on Networth / Equity (%), as of Mar 24, the value is -3.89. This value is below the healthy minimum of 15. It has decreased from 6.67 (Mar 23) to -3.89, marking a decrease of 10.56.
- For Return on Capital Employeed (%), as of Mar 24, the value is -2.07. This value is below the healthy minimum of 10. It has decreased from 11.75 (Mar 23) to -2.07, marking a decrease of 13.82.
- For Return On Assets (%), as of Mar 24, the value is -2.95. This value is below the healthy minimum of 5. It has decreased from 4.91 (Mar 23) to -2.95, marking a decrease of 7.86.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.07 (Mar 23) to 0.05, marking a decrease of 0.02.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.08. This value is within the healthy range. It has decreased from 0.09 (Mar 23) to 0.08, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.46. It has decreased from 0.55 (Mar 23) to 0.46, marking a decrease of 0.09.
- For Current Ratio (X), as of Mar 24, the value is 1.23. This value is below the healthy minimum of 1.5. It has decreased from 1.68 (Mar 23) to 1.23, marking a decrease of 0.45.
- For Quick Ratio (X), as of Mar 24, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 1.13 (Mar 23) to 0.67, marking a decrease of 0.46.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 6.75. This value is within the healthy range. It has increased from 6.45 (Mar 23) to 6.75, marking an increase of 0.30.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is -73.02. This value is below the healthy minimum of 20. It has decreased from 17.92 (Mar 23) to -73.02, marking a decrease of 90.94.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 123.03. This value exceeds the healthy maximum of 50. It has increased from 10.70 (Mar 23) to 123.03, marking an increase of 112.33.
- For Earning Retention Ratio (%), as of Mar 24, the value is 173.02. This value exceeds the healthy maximum of 70. It has increased from 82.08 (Mar 23) to 173.02, marking an increase of 90.94.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is -23.03. This value is below the healthy minimum of 40. It has decreased from 89.30 (Mar 23) to -23.03, marking a decrease of 112.33.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 5.07. This value is within the healthy range. It has decreased from 59.43 (Mar 23) to 5.07, marking a decrease of 54.36.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is -1.97. This value is below the healthy minimum of 3. It has decreased from 30.58 (Mar 23) to -1.97, marking a decrease of 32.55.
- For Enterprise Value (Cr.), as of Mar 24, the value is 5,324.43. It has increased from 4,435.11 (Mar 23) to 5,324.43, marking an increase of 889.32.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.40. This value is within the healthy range. It has increased from 0.98 (Mar 23) to 1.40, marking an increase of 0.42.
- For EV / EBITDA (X), as of Mar 24, the value is 23.55. This value exceeds the healthy maximum of 15. It has increased from 3.83 (Mar 23) to 23.55, marking an increase of 19.72.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.30. This value is within the healthy range. It has increased from 0.95 (Mar 23) to 1.30, marking an increase of 0.35.
- For Retention Ratios (%), as of Mar 24, the value is 173.02. This value exceeds the healthy maximum of 70. It has increased from 82.07 (Mar 23) to 173.02, marking an increase of 90.95.
- For Price / BV (X), as of Mar 24, the value is 0.81. This value is below the healthy minimum of 1. It has increased from 0.70 (Mar 23) to 0.81, marking an increase of 0.11.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.30. This value is within the healthy range. It has increased from 0.95 (Mar 23) to 1.30, marking an increase of 0.35.
- For EarningsYield, as of Mar 24, the value is -0.04. This value is below the healthy minimum of 5. It has decreased from 0.09 (Mar 23) to -0.04, marking a decrease of 0.13.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gujarat Alkalies & Chemicals Ltd:
- Net Profit Margin: -3.47%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -2.07% (Industry Average ROCE: 9.52%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -3.89% (Industry Average ROE: 6.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -1.97
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.67
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 61.63)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.08
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -3.47%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Chemicals - Inorganic - Caustic Soda/Soda Ash | P.O.: Ranoli Vadodra District Gujarat 391350 | investor_relations@gacl.co.in http://www.gacl.com |
Management | |
---|---|
Name | Position Held |
Dr. Hasmukh Adhia | Chairman |
Mr. P Swaroop | Managing Director |
Mr. Rajiv Lochan Jain | Independent Director |
Mr. Nitin Shukla | Independent Director |
Mr. Shridevi Shukla | Independent Director |
Dr. Rahul Gupta | Director |
Mr. Bimal Julka | Independent Director |
Dr. Chinmay Ghoroi | Independent Director |
FAQ
What is the intrinsic value of Gujarat Alkalies & Chemicals Ltd?
Gujarat Alkalies & Chemicals Ltd's intrinsic value (as of 02 April 2025) is ₹399.88 — 38.29% lower the current market price of ₹648.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 4,752 Cr. market cap, FY2025-2026 high/low of ₹900/484, reserves of 6,112 Cr, and liabilities of 8,413 Cr.
What is the Market Cap of Gujarat Alkalies & Chemicals Ltd?
The Market Cap of Gujarat Alkalies & Chemicals Ltd is 4,752 Cr..
What is the current Stock Price of Gujarat Alkalies & Chemicals Ltd as on 02 April 2025?
The current stock price of Gujarat Alkalies & Chemicals Ltd as on 02 April 2025 is 648.
What is the High / Low of Gujarat Alkalies & Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Gujarat Alkalies & Chemicals Ltd stocks is ₹900/484.
What is the Stock P/E of Gujarat Alkalies & Chemicals Ltd?
The Stock P/E of Gujarat Alkalies & Chemicals Ltd is .
What is the Book Value of Gujarat Alkalies & Chemicals Ltd?
The Book Value of Gujarat Alkalies & Chemicals Ltd is 842.
What is the Dividend Yield of Gujarat Alkalies & Chemicals Ltd?
The Dividend Yield of Gujarat Alkalies & Chemicals Ltd is 0.00 %.
What is the ROCE of Gujarat Alkalies & Chemicals Ltd?
The ROCE of Gujarat Alkalies & Chemicals Ltd is 3.83 %.
What is the ROE of Gujarat Alkalies & Chemicals Ltd?
The ROE of Gujarat Alkalies & Chemicals Ltd is 3.88 %.
What is the Face Value of Gujarat Alkalies & Chemicals Ltd?
The Face Value of Gujarat Alkalies & Chemicals Ltd is 10.0.